Book ReviewsBreast CancerSurvivorship

Sharing Our 3 Stories as Breast Cancer Survivors

In Hope Among Us, Rhonda, Jennifer, and Mari share their personal experiences with cancer and interview family members for their insights on how the disease affects all facets of life.
October 2021 Vol 7 No 5
Rhonda Eyzaguirre, PhD
Elk Grove, California
Jennifer Dresser
Elk Grove, California
Mari Guzman
Elk Grove, California

Nine years ago, Rhonda and Mari met when their sons started preschool in the same class. And Rhonda and Jennifer met 5 years ago, when their daughters started kindergarten together. We all became friends through our children, and have many shared experiences, including our breast cancer diagnoses.

Our Many Bonds

We also had another bond: all 3 of us were diagnosed with the same kind of breast cancer—ER-positive, PR-positive, HER2-negative invasive ductal carcinoma. We were all diagnosed at the same hospital at a young age (between ages 37 and 42). In addition, we are all daughters of breast cancer survivors.

Despite our similarities, we each had unique challenges in our breast cancer journeys. Rhonda had a variant of uncertain significance on her BRCA2 gene, and had 13 tumors. Jennifer was diagnosed in 2012 and had a recurrence in 2019. Mari had 11 positive lymph nodes, and has dealt with getting treatment during COVID-19.

Sharing Our Experiences

During the COVID-19 pandemic, we all met to provide support and encouragement, because Jennifer and Mari were still going through treatment. As young breast cancer survivors, we decided to collaborate and document our experiences on paper, which led to our recently published book—Hope Among Us: Stories of Three Young Breast Cancer Survivors.

This book was written for patients with breast cancer, cancer survivors, caregivers, healthcare providers, and anyone intrigued by the rise of breast cancer in young women.

In this book, we share our unique perspectives, while exploring our experiences battling breast cancer through the optimistic and inspirational lens of hope. We present our experiences through different lenses of time in survivorship—1 month, 6 months, and 3 years.

What the Book Offers

In this book, we provide raw, honest accounts of our breast cancer journeys. We also interviewed our mothers to understand their experiences as breast cancer survivors.

In addition, we interviewed our spouses and children for their perspectives on how cancer affects the entire family. And we share resources that other people can use during their treatment and survivorship periods.

Our stories of hope and triumph are told in the following 5 chronological parts:

I. Our Lives Before Cancer

II. Our Diagnoses

III. Treatment

IV. Interviews

V. Survivorship and Resources.

Part I introduces our personal backgrounds and focuses on major life events, family composition, and medical history that help form our backstories.

Part II recounts in detail each author’s specific experience of receiving a breast cancer diagnosis and her decision-making process.

Part III covers our treatments, including chemotherapy, radiation, surgeries, and hormone therapy. One of Jennifer’s surgeries, and part of Mari’s chemotherapy, radiation, and surgeries, occurred during COVID-19, which greatly affected our treatments. The COVID-19 pandemic has challenged us in several ways. Mari aptly used the term “C-squared” to describe the experience of cancer during COVID-19.

Part IV explores our breast cancer diagnoses and treatment through the eyes of family members. We interviewed our mothers as breast cancer survivors to reflect their unique perspectives. We also interviewed our spouses to understand the experience of cancer from family members. And we interviewed our combined 8 children, ranging in age from 7 to 22, and captured a wide developmental perspective. The book is available on Amazon.

Navigating Survivorship

The final part is focused on how we are navigating the survivorship phase and provides relevant resources for other survivors.

The first 2 chapters provide 2 unique lenses of survivorship—social and spiritual—that can be used to foster resilience in survivorship. Rhonda’s 2 main survivorship programs coincided with COVID-19.

Marquina Iliev-Piseli, a breast cancer survivor and an author in New York, shared her perspective on the book: “I love this book. Thanks to the 3 women who are profiled in these stories. They show the entire journey through all the phases of dealing with a cancer journey and recovery…and sometimes recurrence. This book is a great gift for anyone going through breast cancer diagnosis for the first, or perhaps the second time. Big love and hugs to anyone touched by cancer.”

Another author in California, Gloria Ng, observed: “What I found most wonderful about the book is the plethora of resources available for other people who may be experiencing the effects of breast cancer on family life. Their stories also include braving treatment and travel during the global pandemic brought about by COVID-19. In essence, I highly recommend this book for newly diagnosed patients and survivors and their families and allies and anyone who is interested in understanding how breast cancer affects people and their families.”

Share this:

Recommended For You
Patient StoriesProstate CancerSurvivorship
How I Learned to Be Vulnerable: Sharing My Prostate Cancer Story Helped My Healing
By Mark DeLong
A decade after his son passed away from a rare form of bone cancer at age 16, Mark DeLong was diagnosed with prostate cancer. He learned, among other things, the healing power of being vulnerable and sharing personal stories.
COVID-19 & CancerSurvivorship
Delayed Cancer Screening Because of COVID-19 Fears Could Cost Lives
By Maurie Markman, MD
Dr. Maurie Markman explains that missing multiple doctors’ appointments because of the COVID-19 pandemic could have a profound impact on people’s health, because of delayed diagnosis and treatment of cancer.
Colorectal CancerMen's HealthSurvivorship
What It Really Means to “Man Up”
By Joe Bullock
Six months before he was diagnosed with stage IIIB colorectal cancer, both of Joe Bullock’s parents passed away. Chemotherapy hit him hard and stirred a mixture of depression and feelings of inadequacy as a husband and father. Then he discovered the power of opening up.
FDA Approvals, News & UpdatesBreast Cancer
Verzenio First CDK4/6 Approved with Endocrine Therapy for Adjuvant Treatment of Early Breast Cancer
In October 2021, the FDA approved the combination of Verzenio (abemaciclib), a CDK 4/6 inhibitor, plus endocrine therapy for adjuvant treatment (after surgery) of adults with HR-positive, HER2-negative, node-positive, early breast cancer that is at high risk of recurrence.
Last modified: December 3, 2021

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Race or Ethnicity
Profession or Role
Primary Interest